182 related articles for article (PubMed ID: 35788069)
1. Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial.
Sun Y; Feng W; Chen J; Liu M; Shi X; Wang J; Zou L; Xu T; Yang G
BMJ Open; 2022 Jul; 12(7):e057970. PubMed ID: 35788069
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of melatonin supplementation as an add-on treatment for infantile epileptic spasms syndrome: A randomized, placebo-controlled, double-blind trial.
Sun Y; Chen J; Shi X; Li Z; Wan L; Yan H; Chen Y; Wang J; Wang J; Zou L; Reiter R; Zhang B; Yang G
J Pineal Res; 2024 Jan; 76(1):e12922. PubMed ID: 37909654
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.
Menczel Schrire Z; Phillips CL; Duffy SL; Marshall NS; Mowszowski L; La Monica HM; Gordon CJ; Chapman JL; Saini B; Lewis SJG; Naismith SL; Grunstein RR; Hoyos CM
BMJ Open; 2021 Feb; 11(2):e041500. PubMed ID: 33568368
[TBL] [Abstract][Full Text] [Related]
4. Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a Better Outcome with Melatonin compared to Placebo Administered to normalize sleep-wake cycle and treat hypoactive ICU Delirium: the Basel BOMP-AID study.
Hollinger A; von Felten S; Sutter R; Huber J; Tran F; Reinhold S; Abdelhamid S; Todorov A; Gebhard CE; Cajochen C; Steiner LA; Siegemund M
BMJ Open; 2020 Apr; 10(4):e034873. PubMed ID: 32354780
[TBL] [Abstract][Full Text] [Related]
5. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
[TBL] [Abstract][Full Text] [Related]
6. Treatment of infantile spasms.
Hancock E; Osborne J; Milner P
Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
[TBL] [Abstract][Full Text] [Related]
7. Treatment of infantile spasms.
Hancock E; Osborne JP; Milner P
Cochrane Database Syst Rev; 2002; (2):CD001770. PubMed ID: 12076419
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
9. The treatment of West syndrome: a Cochrane review of the literature to December 2000.
Hancock E; Osborne JP; Milner P
Brain Dev; 2001 Nov; 23(7):624-34. PubMed ID: 11701267
[TBL] [Abstract][Full Text] [Related]
10. Combined melatonin and adrenocorticotropic hormone treatment attenuates N-methyl-d-aspartate-induced infantile spasms in a rat model by regulating activation of the HPA axis.
Wan L; Yang G; Sun Y; Li Z; Zhang S; Shi X; Wang J
Neurosci Lett; 2021 Mar; 748():135713. PubMed ID: 33571576
[TBL] [Abstract][Full Text] [Related]
11. Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China.
Zou LP; Wang X; Dong CH; Chen CH; Zhao W; Zhao RY
Clin Ther; 2010 Apr; 32(4):692-700. PubMed ID: 20435238
[TBL] [Abstract][Full Text] [Related]
12. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
[TBL] [Abstract][Full Text] [Related]
13. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A
Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698
[TBL] [Abstract][Full Text] [Related]
14. Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.
Palmer KR; Mockler JC; Davies-Tuck ML; Miller SL; Goergen SK; Fahey MC; Anderson PJ; Groom KM; Wallace EM
BMJ Open; 2019 Jun; 9(6):e028243. PubMed ID: 31230020
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
[TBL] [Abstract][Full Text] [Related]
16. Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.
Adam R; Kanakarajan S; Onyeakazi U; Columb M; Galley H
BMJ Open; 2020 Mar; 10(3):e034443. PubMed ID: 32184313
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial.
Russcher M; Koch BC; Nagtegaal JE; van Ittersum FJ; Pasker-de Jong PC; Hagen EC; van Dorp WT; Gabreëls B; Wildbergh TX; van der Westerlaken MM; Gaillard CA; Ter Wee PM
Br J Clin Pharmacol; 2013 Nov; 76(5):668-79. PubMed ID: 23432361
[TBL] [Abstract][Full Text] [Related]
19. Effect of melatonin in patients with low anterior resection syndrome (MELLARS): a study protocol for a randomised, placebo-controlled, crossover trial.
Zahid JA; Madsen MT; Bulut O; Christensen P; Gögenur I
BMJ Open; 2023 Sep; 13(9):e067763. PubMed ID: 37696629
[TBL] [Abstract][Full Text] [Related]
20. Melatonin, temazepam and placebo in hospitalised older patients with sleeping problems (MATCH): a study protocol of randomised controlled trial.
Stenveld F; Bosman S; van Munster BC; Beishuizen SJ; Hempenius L; van der Velde N; Smidt N; de Rooij SE
BMJ Open; 2019 May; 9(5):e025514. PubMed ID: 31122969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
